BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23313430)

  • 1. Potential conformational heterogeneity of p53 bound to S100B(ββ).
    McDowell C; Chen J; Chen J
    J Mol Biol; 2013 Mar; 425(6):999-1010. PubMed ID: 23313430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the negative regulatory domain of p53 bound to S100B(betabeta).
    Rustandi RR; Baldisseri DM; Weber DJ
    Nat Struct Biol; 2000 Jul; 7(7):570-4. PubMed ID: 10876243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural changes in the C-terminus of Ca2+-bound rat S100B (beta beta) upon binding to a peptide derived from the C-terminal regulatory domain of p53.
    Rustandi RR; Baldisseri DM; Drohat AC; Weber DJ
    Protein Sci; 1999 Sep; 8(9):1743-51. PubMed ID: 10493575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsically disordered p53 extreme C-terminus binds to S100B(betabeta) through "fly-casting".
    Chen J
    J Am Chem Soc; 2009 Feb; 131(6):2088-9. PubMed ID: 19216110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragmenting the S100B-p53 interaction: combined virtual/biophysical screening approaches to identify ligands.
    Agamennone M; Cesari L; Lalli D; Turlizzi E; Del Conte R; Turano P; Mangani S; Padova A
    ChemMedChem; 2010 Mar; 5(3):428-35. PubMed ID: 20077460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational screening and design of S100B ligand to block S100B-p53 interaction.
    Whitlow JL; Varughese JF; Zhou Z; Bartolotti LJ; Li Y
    J Mol Graph Model; 2009; 27(8):969-77. PubMed ID: 19324580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecules bound to unique sites in the target protein binding cleft of calcium-bound S100B as characterized by nuclear magnetic resonance and X-ray crystallography.
    Charpentier TH; Wilder PT; Liriano MA; Varney KM; Zhong S; Coop A; Pozharski E; MacKerell AD; Toth EA; Weber DJ
    Biochemistry; 2009 Jul; 48(26):6202-12. PubMed ID: 19469484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction.
    Markowitz J; Chen I; Gitti R; Baldisseri DM; Pan Y; Udan R; Carrier F; MacKerell AD; Weber DJ
    J Med Chem; 2004 Oct; 47(21):5085-93. PubMed ID: 15456252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53.
    Markowitz J; Rustandi RR; Varney KM; Wilder PT; Udan R; Wu SL; Horrocks WD; Weber DJ
    Biochemistry; 2005 May; 44(19):7305-14. PubMed ID: 15882069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100B(betabeta) inhibits the protein kinase C-dependent phosphorylation of a peptide derived from p53 in a Ca2+-dependent manner.
    Wilder PT; Rustandi RR; Drohat AC; Weber DJ
    Protein Sci; 1998 Mar; 7(3):794-8. PubMed ID: 9541413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy.
    Drohat AC; Amburgey JC; Abildgaard F; Starich MR; Baldisseri D; Weber DJ
    Biochemistry; 1996 Sep; 35(36):11577-88. PubMed ID: 8794737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12.
    Inman KG; Yang R; Rustandi RR; Miller KE; Baldisseri DM; Weber DJ
    J Mol Biol; 2002 Dec; 324(5):1003-14. PubMed ID: 12470955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A structural basis for S100 protein specificity derived from comparative analysis of apo and Ca(2+)-calcyclin.
    Mäler L; Sastry M; Chazin WJ
    J Mol Biol; 2002 Mar; 317(2):279-90. PubMed ID: 11902843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling of single polypeptide chain of calcium-binding protein p26olf from dimeric S100B(betabeta).
    Tanaka T; Miwa N; Kawamura S; Sohma H; Nitta K; Matsushima N
    Protein Eng; 1999 May; 12(5):395-405. PubMed ID: 10360980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53.
    van Dieck J; Teufel DP; Jaulent AM; Fernandez-Fernandez MR; Rutherford TJ; Wyslouch-Cieszynska A; Fersht AR
    J Mol Biol; 2009 Dec; 394(5):922-30. PubMed ID: 19819244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure of calcium-bound rat S100B(betabeta) as determined by nuclear magnetic resonance spectroscopy,
    Drohat AC; Baldisseri DM; Rustandi RR; Weber DJ
    Biochemistry; 1998 Mar; 37(9):2729-40. PubMed ID: 9485423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location of the Zn(2+)-binding site on S100B as determined by NMR spectroscopy and site-directed mutagenesis.
    Wilder PT; Baldisseri DM; Udan R; Vallely KM; Weber DJ
    Biochemistry; 2003 Nov; 42(46):13410-21. PubMed ID: 14621986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ca(2+)-dependent interaction of S100B(beta beta) with a peptide derived from p53.
    Rustandi RR; Drohat AC; Baldisseri DM; Wilder PT; Weber DJ
    Biochemistry; 1998 Feb; 37(7):1951-60. PubMed ID: 9485322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C-terminus and linker region of S100B exert dual control on protein-protein interactions with TRTK-12.
    McClintock KA; Van Eldik LJ; Shaw GS
    Biochemistry; 2002 Apr; 41(17):5421-8. PubMed ID: 11969402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural influence of cation binding to recombinant human brain S100b: evidence for calcium-induced exposure of a hydrophobic surface.
    Smith SP; Barber KR; Dunn SD; Shaw GS
    Biochemistry; 1996 Jul; 35(27):8805-14. PubMed ID: 8688416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.